Toronto Dominion Bank
JAZZ icon

Toronto Dominion Bank’s Jazz Pharmaceuticals JAZZ Stock Holding History

Toronto Dominion Bank’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-7,482
Closed -$901K – 1486
2024
Q1 		$901K Sell
7,482
-2,091
-22% -$256K ﹤0.01% 894
2023
Q4 		$1.18M Sell
9,573
-4,432
-32% -$553K ﹤0.01% 956
2023
Q3 		$1.81M Buy
+14,005
New +$1.87M ﹤0.01% 880
2019
Q2 		– Sell
-10,858
Closed -$1.55M – 1610
2019
Q1 		$1.55M Buy
10,858
+2,725
+34% +$355K ﹤0.01% 886
2018
Q4 		$1.01M Buy
8,133
+1,617
+25% +$240K ﹤0.01% 888
2018
Q3 		$1.09M Buy
6,516
+556
+9% +$95.6K ﹤0.01% 873
2018
Q2 		$1.03M Buy
5,960
+1,856
+45% +$303K ﹤0.01% 910
2018
Q1 		$619K Buy
4,104
+563
+16% +$82.6K ﹤0.01% 895
2017
Q4 		$477K Buy
3,541
+1,006
+40% +$140K ﹤0.01% 899
2017
Q3 		$371K Buy
2,535
+1,799
+244% +$272K ﹤0.01% 812
2017
Q2 		$114K Buy
736
+81
+12% +$12.4K ﹤0.01% 925
2017
Q1 		$95K Buy
655
+130
+25% +$16.9K ﹤0.01% 950
2016
Q4 		$57K Buy
+525
New +$58.5K ﹤0.01% 998
2016
Q2 		– Sell
-337
Closed -$44K – 1231
2016
Q1 		$44K Buy
+337
New +$41.9K ﹤0.01% 943

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.22B AUM 26.01% 1-Year Est. Return

Toronto Dominion Bank's JAZZ Position: Q2 2024 in Review

Toronto Dominion Bank sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2024, closing a stake of 7,482 shares — an estimated $901K sold.

Toronto Dominion Bank first reported a position in JAZZ in Q1 2016 and held it in 14 quarters. The position peaked at $1.81M in Q3 2023. 455 funds tracked by Wall St. Rank hold JAZZ as of Q2 2024.

  • Toronto Dominion Bank reported no remaining Jazz Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Toronto Dominion Bank sold 7,482 Jazz Pharmaceuticals shares in Q2 2024, an estimated $901K.
  • Toronto Dominion Bank first reported a position in Jazz Pharmaceuticals in Q1 2016 and held it in 14 quarters.
  • Toronto Dominion Bank's Jazz Pharmaceuticals position peaked at $1.81M in Q3 2023.
  • 455 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2024.

Based on Toronto Dominion Bank's 13F filing for Q2 2024, filed 14 Aug 2024.